Reimagining Genomics Data Analysis: Interview with Paolo Di Tommaso from Seqera Labs
Exploring the future of genomics data analysis and data sharing
With BioNTech’s recent $200 million merger with OncoC4’s cancer drug, the demand for personalised medicines to treat diseases such as cancer continues to grow. Much of this development stems from pharmaceutical biotech companies sharing their cutting-edge bioinformatics data on open-source platforms for others to use.
Keep reading with a 7-day free trial
Subscribe to Where Tech Meets Bio to keep reading this post and get 7 days of free access to the full post archives.